Movement Alert|Teradyne Intraday Rise 14.73% in Regular Trading, Q2 Earnings and Revenue Massively Beat Expectations with Strong Q3 Guidance

Market Focus
Jul 29

On July 29, Teradyne rose 14.73% in regular trading, trading at $359.63/share, with turnover of $209 million. The surge was driven by the company's Q2 earnings report released after the prior session's close, which significantly exceeded market expectations.

Teradyne reported Q2 adjusted EPS of $2.47, far surpassing the analyst consensus of $2.09, representing a 333% increase from $0.57 a year earlier. Revenue reached $1.33 billion, up 104% year-over-year from $651.8 million, beating the expected $1.22 billion. Net income surged to $374.5 million from $78.4 million in the prior year. The semiconductor test segment contributed $1.122 billion, serving as the core growth engine fueled by AI chip testing demand and advanced packaging investments.

Q3 guidance was equally impressive, with projected adjusted EPS of $1.85 to $2.15 (midpoint $2.00) versus the $1.44 consensus, and revenue guidance of $1.2 billion to $1.3 billion, well above the Street estimate of $1.06 billion. Multiple investment banks including UBS, JPMorgan, and Goldman Sachs have recently raised price targets to the $450-$500 range.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10